31AUG

Welcome To Mediterr J Med Res

Manuscripts are accepted for consideration with understanding that they are represent original material and they are not being considered for publication elsewhere. The editors welcome the submission of relevant articles for editorial consideration. Manuscripts and all scientific and professional data should be addressed to Editor-in-Cheif (Fmosherif@yahoo.com).

Mediterranean Journal of Medical Research
http://www.mjpe.periodikos.com.br/article/doi/10.5281/zenodo.15455698

Mediterranean Journal of Medical Research

Original article

Knowledge, attitudes, and practice of pharmacists in opioid abuse prevention: A cross-sectional study in Mangalore, India

Arjun Rai M., Ramdas Bhat , A. R. Shabaraya

Downloads: 3
Views: 202

Abstract

The international opioid crisis highlights the important role of pharmacists in prevention, using their availability and drug knowledge to prevent abuse. In this study, the knowledge, attitudes, and practices of Mangalore pharmacists towards preventing opioid abuse were assessed. From February to March 2025, a cross-sectional survey was done among 203 pharmacists aged 18-46 years in Mangalore using a pre-tested structured questionnaire. Data were analyzed using the Chi-square test, and thematic analysis of qualitative feedback. Pharmacists showed high knowledge, with 93.6% identifying opioids' mechanism as binding to CNS receptors correctly, 78.8% identifying naloxone's role in reversing overdose, and 70.0% knowing prescription drug monitoring programs' usefulness. Attitudes were optimistic, with 92.6% considering patient education a primary responsibility, 92.1% identifying multiple visits to the pharmacy as misuse, and 93.1% supporting medication-assisted treatment. The practice was active, with 93.1% checking prescription drug monitoring programs for suspected misuse and 69.0% advising take-back programs, but 43.8% associated early refills with misuse. Mangalore pharmacists show strong knowledge, attitudes, and practice against opioid abuse, being very strong in education and medication-assisted treatment support but having voids in misuse detection (for example, recognition of early refill) and naloxone confidence. Stronger training, better prescription drug monitoring program access, and policy adjustments can enhance their role in India's opioid strategy. Pharmacists are presented as front-line champions of opioid misuse prevention in this study, with implications for localized harm reduction.

Keywords

Attitude, harm reduction, knowledge, opioid abuse, pharmacist 

References

  1. Dhalla IA, Persaud N, Juurlink DN (2011) Facing up to the prescription opioid crisis. British Medical Journal. 343: d5142. doi: 10.1136/bmj.d5142
  2. Cicero TJ, Ellis MS, Kasper ZA (2017) Increased use of heroin as an initiating opioid of abuse. Addict Behav. 74: 63-66. doi: 10.1016/j.addbeh.2017.05.030
  3. Compton WM, Jones CM, Baldwin GT, Ramesh K, Iyer V, Sullivan G (2016) Relationship between nonmedical prescription-opioid use and heroin use. The New England Journal of Medicine. 374 (2): 154-163. doi: 10.1056/ NEJMsa1500628
  4. Fleming ML, Chandwani H, Barner JC, Chacko J, Fernandez M, Taylor D (2013) Prescribers and pharmacists requests for prescription monitoring program (PMP) data: Does PMP structure matter? Journal of Pain and Palliative Care Pharmacotherapy. 27 (2): 136-142. doi: 10.3109/15360288.2013.787287
  5. Thornton JD, Lyvers E, Scott VG, Dwibedi N (2017) Pharmacists’ readiness to provide naloxone in community pharmacies in West Virginia. Journal of the American Pharmacists Association. 57 (2 Suppl): S12-S18.e4. doi: 10.1016/j.japh.2016.10.003
  6. Green TC, Mann MR, Bowman SE, Zaman K, Rao P, Liu C (2013) How does use of a prescription monitoring program change pharmacy practice? Journal of the American Pharmacists Association. 53 (3): 273-81. doi: 10.1331/ JAPhA.2013.12094
  7. Muzyk A, Smothers ZPW, Collins K, Patel N, Dubey R, Singh A (2019) Pharmacists’ attitudes toward dispensing naloxone and medications for opioid use disorder: A scoping review of the literature. Substance Abuse. 40 (4): 476-83. doi: 10.1080/08897077.2019.1616349
  8. Gugelmann H, Shofer FS, Meisel ZF, Perrone J, Clarke E, Jackson D (2013) Multidisciplinary intervention decreases the use of opioid medication discharge packs from two urban EDs. American Journal of Emergency Medicine. 31 (9): 1343-1348. doi:10.1016/j.ajem.2013.04.022
  9. Strand MA, Eukel H, Burck S, Ahmad S, Pinto R, Verghese T (2019) Moving opioid misuse prevention upstream: A pilot study of community pharmacists screening for opioid misuse risk. Research in Social and Administrative Pharmacy. 15 (8): 1032-1036. doi:10.1016/j.sapharm.2018.10.008
  10. Nielsen S, Menon N, Larney S, Kumar A, Das M, Tiwari R (2016) Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal. Addiction. 111 (12): 2177-2186. doi: 10.1111/add.13567
  11. Binswanger IA, Stern MF, Deyo RA, Heitman B, McDonald C, Rajan A (2007) Release from prison-a high risk of death for former inmates. The New England Journal of Medicine. 356 (2): 157-165. doi: 10.1056/NEJMsa064115
  12. Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, Alexander GC (2015) The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annual Review of Public Health. 36: 559-574. doi: 10.1146/annurev-publhealth-031914-122957
  13. Sharma V, Gupta S, Kumar R, Fernandes B, Nair R, Joseph T (2018) Role of pharmacists in combating opioid misuse in urban India. Indian Journal of Pharmacy Practice. 11 (3): 123-129. doi: 10.5530/ijopp.11.3.23
  14. Singh B, Rao R (2021) Is there an opioid epidemic in India? Journal of Public Health. 43 (S2): ii43-ii50. doi: 10.1093/pubmed/fdab322
  15. Bachhuber MA, Hennessy S, Cunningham CO, Starling R, Douglas K, Rivera L (2016) Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013. American Journal of Public Health. 106 (4): 686-688. doi: 10.2105/AJPH.2016.303061
  16. Dowell D, Haegerich TM, Chou R (2016) CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA. 315 (15): 1624-1645. doi: 10.1001/jama.2016.1464
  17. Alssageer MA, Khattab BF, Bakouri AH (2024) Physicians' attitudes, expectations, and experiences about clinical pharmacists and the barriers they have in developing a collaborative relationship with them. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 4 (3): 27-38. doi: 10.5281/zenodo.13324209
  18. Alkilane IAA, Alssageer MA, Almahdi FA, Ahmed FK (2024) Knowledge and attitudes regarding topical misuse of corticosteroids in Libya. Mediterr J Pharm Pharm Sci. 4 (1): 111-120. doi: 10.5281/zenodo.10732533
  19. Habiba F, Saleh A, Boudia F, Bettayeb A, Zine-eddine Ouadeh MZ, Labiod DA, Kefif O, Mekaouche N, Memou A, Adli FZ, Toumi H (2023) Knowledge, attitude, and practice of healthcare professionals on dose adjustment of acenocoumarol in Algeria. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 3 (2): 4-12. doi: 10.5281/zenodo.7865373
  20. Elfituri AA, Sherif FM (2022) Novel clinical pharmacy practice: Extended role and improved competencies. Journal of Pharmacy and Pharmaceutical Sciences. 2 (1): 1-3. doi: 10.5281/zenodo.6397651

Submitted date:
04/30/2025

Reviewed date:
05/11/2025

Accepted date:
05/16/2025

6829a564a9539506c935d352 mjpe Articles
Links & Downloads

Mediterr J Med Res

Share this page
Page Sections